Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | SF3A2 |
| Upstream (Parents) |
|---|
| (<<) ADAM10 → SF3A2 |
| (<<) CFL1 → SF3A2 |
| (<<) COIL → SF3A2 |
| (<<) CSNK1A1 → SF3A2 |
| (<<) DVL1 → SF3A2 |
| (<<) EIF4E → SF3A2 |
| (<<) GLTPD1 → SF3A2 |
| (<<) HSPA8 → SF3A2 |
| (<<) MAT2A → SF3A2 |
| (<<) PPIF → SF3A2 |
| (<<) RAC1 → SF3A2 |
| (<<) RASA1 → SF3A2 |
| (<<) RHOG → SF3A2 |
| (<<) RNF11 → SF3A2 |
| (<<) SH3GL1 → SF3A2 |
| (<<) SHFM1 → SF3A2 |
| (<<) SMARCC2 → SF3A2 |
| (<<) TCOF1 → SF3A2 |
| (<<) UGDH → SF3A2 |
| (<<) WNT5B → SF3A2 |
| Downstream (Children) |
|---|
| SF3A2 → ALPPL2 (>>) |
| SF3A2 → BMPR1A (>>) |
| SF3A2 → CCL24 (>>) |
| SF3A2 → CD83 (>>) |
| SF3A2 → ELF1 (>>) |
| SF3A2 → EPHB6 (>>) |
| SF3A2 → FLJ22184 (>>) |
| SF3A2 → FOSL1 (>>) |
| SF3A2 → FZD9 (>>) |
| SF3A2 → GNA15 (>>) |
| SF3A2 → MAP3K11 (>>) |
| SF3A2 → MAP3K3 (>>) |
| SF3A2 → MT1P2 (>>) |
| SF3A2 → NEDD4 (>>) |
| SF3A2 → NET1 (>>) |
| SF3A2 → NOTCH4 (>>) |
| SF3A2 → PALM (>>) |
| SF3A2 → PLA2G6 (>>) |
| SF3A2 → PLAUR (>>) |
| SF3A2 → PSORS1C2 (>>) |
| SF3A2 → RCBTB1 (>>) |
| SF3A2 → RYK (>>) |
| SF3A2 → SGSH (>>) |
| SF3A2 → SPATA2L (>>) |
| SF3A2 → STK17B (>>) |
| SF3A2 → TYRO3 (>>) |
| SF3A2 → UBE2J1 (>>) |
